Artificial intelligence (AI), using a simple blood test combined with standard brain images has, for the first time, been able to identify two biologically distinct types of multiple sclerosis (MS), ...

The FDA agreed to speed its review of a Roche drug the developer says could be the first oral high-efficacy therapy approved ...

Multiple Sclerosis (MS) is a chronic neurological autoimmune disease of the central nervous system that affects every individual differently. In the case of MS, it attacks the protective covering of ...

Two novel sub-types of multiple sclerosis (MS) have been identified, a discovery potentially paving the way for new treatments. Researchers employed artificial intelligence (AI) to assess brain scans ...

Multiple sclerosis (MS) is an autoimmune condition in which the protective insulation surrounding neurons in the brain and spinal cord is erroneously attacked. This can cause a wide variety of serious ...